305 related articles for article (PubMed ID: 30576462)
1. Role of Screening History in Clinical Meaning and Optimal Management of Positive Cervical Screening Results.
Castle PE; Kinney WK; Xue X; Cheung LC; Gage JC; Poitras NE; Lorey TS; Katki HA; Wentzensen N; Schiffman M
J Natl Cancer Inst; 2019 Aug; 111(8):820-827. PubMed ID: 30576462
[TBL] [Abstract][Full Text] [Related]
2. The clinician's view: role of human papillomavirus testing in the American Society for Colposcopy and Cervical Pathology Guidelines for the management of abnormal cervical cytology and cervical cancer precursors.
Cox JT;
Arch Pathol Lab Med; 2003 Aug; 127(8):950-8. PubMed ID: 12952506
[TBL] [Abstract][Full Text] [Related]
3. Follow-up testing after colposcopy: five-year risk of CIN 2+ after a colposcopic diagnosis of CIN 1 or less.
Katki HA; Gage JC; Schiffman M; Castle PE; Fetterman B; Poitras NE; Lorey T; Cheung LC; Raine-Bennett T; Kinney WK
J Low Genit Tract Dis; 2013 Apr; 17(5 Suppl 1):S69-77. PubMed ID: 23519308
[TBL] [Abstract][Full Text] [Related]
4. Risk Stratification Using Human Papillomavirus Testing among Women with Equivocally Abnormal Cytology: Results from a State-Wide Surveillance Program.
Gage JC; Hunt WC; Schiffman M; Katki HA; Cheung LC; Cuzick J; Myers O; Castle PE; Wheeler CM;
Cancer Epidemiol Biomarkers Prev; 2016 Jan; 25(1):36-42. PubMed ID: 26518316
[TBL] [Abstract][Full Text] [Related]
5. HPV genotyping for triage of women with abnormal cervical cancer screening results: a multicenter prospective study.
Nakamura Y; Matsumoto K; Satoh T; Nishide K; Nozue A; Shimabukuro K; Endo S; Nagai K; Oki A; Ochi H; Morishita Y; Noguchi M; Yoshikawa H
Int J Clin Oncol; 2015 Oct; 20(5):974-81. PubMed ID: 25652908
[TBL] [Abstract][Full Text] [Related]
6. The low risk of precancer after a screening result of human papillomavirus-negative/atypical squamous cells of undetermined significance papanicolaou and implications for clinical management.
Gage JC; Katki HA; Schiffman M; Castle PE; Fetterman B; Poitras NE; Lorey T; Cheung LC; Behrens C; Sharma A; Zhao FH; Cuzick J; Yang ZH; Kinney WK
Cancer Cytopathol; 2014 Nov; 122(11):842-50. PubMed ID: 25045058
[TBL] [Abstract][Full Text] [Related]
7. Cervical Cancer Screening: A Review.
Perkins RB; Wentzensen N; Guido RS; Schiffman M
JAMA; 2023 Aug; 330(6):547-558. PubMed ID: 37552298
[TBL] [Abstract][Full Text] [Related]
8. HPV testing compared with routine cytology in cervical screening: long-term follow-up of ARTISTIC RCT.
Gilham C; Sargent A; Kitchener HC; Peto J
Health Technol Assess; 2019 Jun; 23(28):1-44. PubMed ID: 31219027
[TBL] [Abstract][Full Text] [Related]
9. Pooled analysis on the necessity of random 4-quadrant cervical biopsies and endocervical curettage in women with positive screening but negative colposcopy.
Hu SY; Zhang WH; Li SM; Li N; Huang MN; Pan QJ; Zhang X; Han Y; Zhao FH; Chen W; Qiao YL
Medicine (Baltimore); 2017 Apr; 96(17):e6689. PubMed ID: 28445270
[TBL] [Abstract][Full Text] [Related]
10. Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice.
Katki HA; Kinney WK; Fetterman B; Lorey T; Poitras NE; Cheung L; Demuth F; Schiffman M; Wacholder S; Castle PE
Lancet Oncol; 2011 Jul; 12(7):663-72. PubMed ID: 21684207
[TBL] [Abstract][Full Text] [Related]
11. Implementation of HPV-based cervical cancer screening in an organised regional screening programme: 3 years of experience.
Veijalainen O; Kares S; Kujala P; Vuento R; Osuala V; Tirkkonen M; Luukkaala T; Kholová I; Mäenpää J
Cytopathology; 2019 Mar; 30(2):150-156. PubMed ID: 30421573
[TBL] [Abstract][Full Text] [Related]
12. Reduction of cervical cancer incidence within a primary HPV screening pilot project (WOLPHSCREEN) in Wolfsburg, Germany.
Horn J; Denecke A; Luyten A; Rothe B; Reinecke-Lüthge A; Mikolajczyk R; Petry KU
Br J Cancer; 2019 May; 120(10):1015-1022. PubMed ID: 30988395
[TBL] [Abstract][Full Text] [Related]
13. Similar Risk Patterns After Cervical Screening in Two Large U.S. Populations: Implications for Clinical Guidelines.
Gage JC; Hunt WC; Schiffman M; Katki HA; Cheung LA; Myers O; Cuzick J; Wentzensen N; Kinney W; Castle PE; Wheeler CM;
Obstet Gynecol; 2016 Dec; 128(6):1248-1257. PubMed ID: 27824767
[TBL] [Abstract][Full Text] [Related]
14. The age-specific relationships of abnormal cytology and human papillomavirus DNA results to the risk of cervical precancer and cancer.
Castle PE; Fetterman B; Thomas Cox J; Shaber R; Poitras N; Lorey T; Kinney W
Obstet Gynecol; 2010 Jul; 116(1):76-84. PubMed ID: 20567171
[TBL] [Abstract][Full Text] [Related]
15. Risks of CIN 2+, CIN 3+, and Cancer by Cytology and Human Papillomavirus Status: The Foundation of Risk-Based Cervical Screening Guidelines.
Demarco M; Lorey TS; Fetterman B; Cheung LC; Guido RS; Wentzensen N; Kinney WK; Poitras NE; Befano B; Castle PE; Schiffman M
J Low Genit Tract Dis; 2017 Oct; 21(4):261-267. PubMed ID: 28953116
[TBL] [Abstract][Full Text] [Related]
16. Effect of Several Negative Rounds of Human Papillomavirus and Cytology Co-testing on Safety Against Cervical Cancer: An Observational Cohort Study.
Castle PE; Kinney WK; Xue X; Cheung LC; Gage JC; Zhao FH; Fetterman B; Poitras NE; Lorey TS; Wentzensen N; Katki HA; Schiffman M
Ann Intern Med; 2018 Jan; 168(1):20-29. PubMed ID: 29181509
[TBL] [Abstract][Full Text] [Related]
17. Risk assessment to guide cervical screening strategies in a large Chinese population.
Zhao FH; Hu SY; Zhang Q; Zhang X; Pan QJ; Zhang WH; Gage JC; Wentzensen N; Castle PE; Qiao YL; Katki HA; Schiffman M
Int J Cancer; 2016 Jun; 138(11):2639-47. PubMed ID: 26800481
[TBL] [Abstract][Full Text] [Related]
18. Comparison of cervical cancer screening results among 256,648 women in multiple clinical practices.
Blatt AJ; Kennedy R; Luff RD; Austin RM; Rabin DS
Cancer Cytopathol; 2015 May; 123(5):282-8. PubMed ID: 25864682
[TBL] [Abstract][Full Text] [Related]
19. Five-year risks of CIN 3+ and cervical cancer among women who test Pap-negative but are HPV-positive.
Katki HA; Schiffman M; Castle PE; Fetterman B; Poitras NE; Lorey T; Cheung LC; Raine-Bennett T; Gage JC; Kinney WK
J Low Genit Tract Dis; 2013 Apr; 17(5 Suppl 1):S56-63. PubMed ID: 23519306
[TBL] [Abstract][Full Text] [Related]
20. Defining the Longitudinal Risk of CIN 3+ for Piedimonte S; Tsang K; Jembere N; Murphy J; Karapetian T; Gao J; McCurdy B; Sacco J; Kupets R
J Low Genit Tract Dis; 2024 Jan; 28(1):7-11. PubMed ID: 37906611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
